Morphine self-administration in mu-opioid receptor-deficient mice.
about
15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuseA gene-based method for detecting gene-gene co-association in a case-control association studyImplications of genome wide association studies for addiction: are our a priori assumptions all wrong?Pharmacotherapy of addictions.Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type miceReward processing by the opioid system in the brain.The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?Responses to drugs of abuse and non-drug rewards in leptin deficient ob/ob mice.Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroinEffects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.A118G mu opioid receptor polymorphism among drug addicts in Malaysia.Mu Opioid Receptors in Gamma-Aminobutyric Acidergic Forebrain Neurons Moderate Motivation for Heroin and Palatable Food.Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine.Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains.Genetic dissociation of morphine analgesia from hyperalgesia in mice.Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.Genetic variation in heroin-induced changes in behaviour: effects of B6 strain dose on conditioned reward and locomotor sensitization in 129-B6 hybrid mice.
P2860
Q26824667-564E16EB-F80C-4070-BC95-64F203613EB6Q34329003-F1E83E58-9085-41AF-A184-31BC50B68226Q34358797-836A9C8A-9211-484C-B95F-6916173E19AFQ34810395-4C5A5893-BC49-41B3-91F2-B6874E1F090FQ35199976-1B64C23B-0C77-40C6-9A99-15E64A231E43Q35786247-107B1FCC-5AA2-4A66-B3F0-E8950BEF71BDQ36110480-5B64A074-320C-4CA6-BD02-397DEC4B6386Q37394324-C459CDBE-1412-4E7B-8D65-BE4B0C805E9EQ38633387-1833FAED-00CF-4870-B466-ED8BEF99D64DQ44069088-A8650A63-F4EC-48B9-B09E-7ECF39CE30E9Q44334798-4D173B4A-055A-42D7-A72E-0F5F840E4FCFQ44343229-FF01BBAA-CA80-4B16-B8FD-1CAD7770B878Q44344913-99C8A115-689B-4898-9164-D3A1FA76A3AAQ44530074-8C40435C-CF30-4E55-A70A-5D9FEB5B6BD0Q45126959-FAA291AA-DBBF-440A-B11F-C27A7D954DFBQ47934009-0D2E28F7-3281-4804-B4AF-3D967BD204DFQ48000594-71A792FB-4EDB-4EB4-944F-503C4B806229Q48808995-0EC14930-D508-4E63-AB6C-2F80CAE9B16D
P2860
Morphine self-administration in mu-opioid receptor-deficient mice.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Morphine self-administration in mu-opioid receptor-deficient mice.
@en
Morphine self-administration in mu-opioid receptor-deficient mice.
@nl
type
label
Morphine self-administration in mu-opioid receptor-deficient mice.
@en
Morphine self-administration in mu-opioid receptor-deficient mice.
@nl
prefLabel
Morphine self-administration in mu-opioid receptor-deficient mice.
@en
Morphine self-administration in mu-opioid receptor-deficient mice.
@nl
P2093
P356
P1476
Morphine self-administration in mu-opioid receptor-deficient mice.
@en
P2093
Brödemann R
Grecksch G
Schroeder H
Thiemann W
P2888
P304
P356
10.1007/S002100000244
P50
P577
2000-06-01T00:00:00Z